Literature DB >> 31067372

Mesenchymal Hamartoma of the Liver and DICER1 Syndrome.

Maria Apellaniz-Ruiz1, Maria Segni1, Matthias Kettwig1, Sylvia Glüer1, Dylan Pelletier1, Van-Hung Nguyen1, Rabea Wagener1, Cristina López1, Karl Muchantef1, Dorothée Bouron-Dal Soglio1, Nelly Sabbaghian1, Mona K Wu1, Stefano Zannella1, Marc R Fabian1, Reiner Siebert1, Jan Menke1, John R Priest1, William D Foulkes1.   

Abstract

Mesenchymal hamartoma of the liver (MHL) is a benign tumor affecting children that is characterized by a primitive myxoid stroma with cystically dilated bile ducts. Alterations involving chromosome 19q13 are a recurrent underlying cause of MHL; these alterations activate the chromosome 19 microRNA cluster (C19MC). Other cases remain unexplained. We describe two children with MHLs that harbored germline DICER1 pathogenic variants. Analysis of tumor tissue from one of the children revealed two DICER1 "hits." Mutations in DICER1 dysregulate microRNAs, mimicking the effect of the activation of C19MC. Our data suggest that MHL is a new phenotype of DICER1 syndrome. (Funded by the Canadian Institutes of Health Research and others.).
Copyright © 2019 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31067372     DOI: 10.1056/NEJMoa1812169

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

Review 1.  Hematologic indices in individuals with pathogenic germline DICER1 variants.

Authors:  Lauren M Vasta; Nicholas E Khan; Cecilia P Higgs; Laura A Harney; Ann G Carr; Anne K Harris; Kris Ann P Schultz; Mary L McMaster; Douglas R Stewart
Journal:  Blood Adv       Date:  2021-01-12

2.  18F-FDG PET/CT findings of mesenchymal hamartoma of the liver in an adolescent.

Authors:  Congcong Yu; Shuang Wu; Xiaofeng Dou; Shuilin Zhao; Hong Zhang; Mei Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-06-25       Impact factor: 9.236

3.  DICER1-associated hepatic cystic neoplasm with pleuropulmonary blastoma-like features: a novel clinicopathologic diagnosis.

Authors:  Sarah G Mitchell; Kris Ann P Schultz; Heather Rytting; Nicolas Kostelecky; D Ashley Hill; Louis P Dehner
Journal:  Mod Pathol       Date:  2021-12-14       Impact factor: 8.209

Review 4.  Imaging of DICER1 syndrome.

Authors:  R Paul Guillerman; William D Foulkes; John R Priest
Journal:  Pediatr Radiol       Date:  2019-10-16

5.  The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss.

Authors:  Bhuvana A Setty; Goodwin G Jinesh; Michael Arnold; Fredrik Pettersson; Chia-Ho Cheng; Ling Cen; Sean J Yoder; Jamie K Teer; Elsa R Flores; Damon R Reed; Andrew S Brohl
Journal:  PLoS Genet       Date:  2020-04-20       Impact factor: 5.917

Review 6.  Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review.

Authors:  Sebastiao N Martins-Filho; Juan Putra
Journal:  Hepat Oncol       Date:  2020-04-07

Review 7.  ETMR: a tumor entity in its infancy.

Authors:  Sander Lambo; Katja von Hoff; Andrey Korshunov; Stefan M Pfister; Marcel Kool
Journal:  Acta Neuropathol       Date:  2020-06-29       Impact factor: 17.088

8.  A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.

Authors:  Uyenlinh L Mirshahi; Jung Kim; Ana F Best; Zongming E Chen; Ying Hu; Jeremy S Haley; Alicia Golden; Richard Stahl; Kandamurugu Manickam; Ann G Carr; Laura A Harney; Amanda Field; Jessica Hatton; Kris Ann P Schultz; Andrew J Bauer; D Ashley Hill; Philip S Rosenberg; Michael F Murray; David J Carey; Douglas R Stewart
Journal:  JAMA Netw Open       Date:  2021-02-01

9.  Ovarian Sertoli-Leydig Cell Tumor, Multinodular Goiter, Cystic Nephromas and DICER1 Mutations: Case Report and Literature Review.

Authors:  Yanglin Ni; Xuan Zhou; Ling Wu; Ping Wu; Ying Liu; Yinnan Li; Li Cai; Xueshu Fu; Chunhua Zhang
Journal:  Pharmgenomics Pers Med       Date:  2021-08-03

10.  Proportion of children with cancer that have an indication for genetic counseling and testing based on the cancer type irrespective of other features.

Authors:  Thi Minh Kha Nguyen; Astrid Behnert; Torsten Pietsch; Christian Vokuhl; Christian Peter Kratz
Journal:  Fam Cancer       Date:  2021-02-26       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.